Effect of drug type on the degradation rate of PLGA matrices
about
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug LoadingNear-infrared-induced heating of confined water in polymeric particles for efficient payload release.Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stabilityA rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing processIbuprofen-loaded poly(lactic-co-glycolic acid) films for controlled drug releaseDesign and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditisMathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a reviewIn vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive.Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.Critical assessment of implantable drug delivery devices in glaucoma management.PLGA: a unique polymer for drug delivery.Modification of TiO(2) nanotube surfaces by electro-spray deposition of amoxicillin combined with PLGA for bactericidal effects at surgical implantation sites.Electrospun PLGA Nanofiber Scaffolds Release Ibuprofen Faster and Degrade Slower After In Vivo Implantation.Controlled and Sequential Delivery of Fluorophores from 3D Printed Alginate-PLGA Tubes.Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.Drug-eluting nasal implants: formulation, characterization, clinical applications and challenges.Controlled initial surge despite high drug fraction and high solubility.Application of time-resolved fluorescence for direct and continuous probing of release from polymeric delivery vehicles.Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles.Transient inhibition of connective tissue infiltration and collagen deposition into porous poly(lactic-co-glycolic acid) discs.Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study.Influence of Ciprofloxacin-based Additives on the Hydrolysis of Nanofiber Polyurethane Membranes.Molecular engineering solutions for therapeutic peptide delivery.Controlled release of clarithromycin from PLGA microspheres enhances bone regeneration in rabbit calvaria defects.Selective Nanoparticle Targeting of the Renal Tubules.Comparison of drug release from poly(lactide-co-glycolide) microspheres and novel fibre formulations.Enhanced Degradation of Lactide-co-Glycolide Polymer with Basic Nucleophilic Drugs
P2860
Q26738335-65621C6D-5FD6-4660-8510-EBB94F1F43CBQ30415679-4F1C81F8-08A7-4BD8-B039-7FC0FE9451EFQ33681249-3A018E22-BABB-491D-9B31-F69B0969994CQ34629537-871E1881-F74E-4A32-A787-7DFBE6EFF79CQ35023323-073ECB34-1D50-4E26-8EFB-8895F988ED6EQ35098278-940ACE5F-CCA7-47EA-B9F7-534364286B66Q36456955-71F5173E-0F11-4106-9658-907E7E80B1C9Q37058223-30350402-5A23-4629-8008-AD13C98025B3Q38101367-C75FFB99-B568-4ADD-9149-C1D2ECDA0D58Q38143069-AF1F5490-E608-4822-B32A-CF24405BE232Q38309875-BB08C38B-21A3-48FE-80C2-5F4245558F15Q38465897-309EB121-B171-4E22-A74C-2AB39C2A8429Q38707717-45443B8F-0568-44CD-B319-2EA8FB04AB67Q38767984-9CD4E798-0B91-488A-A9A0-50E134347E5EQ38813199-2747F742-07E4-49AD-88C1-46B4284F30CEQ38934604-62195D38-9F44-4B63-88A7-CF2FDB3F2E9BQ38940971-51B904B0-8C79-492B-9E7E-CF3C78F733CEQ39011604-7F352881-169D-4135-A0F1-A790A242D7DEQ39185164-C62021A6-590B-45AD-8785-91B1296DD2ABQ39983846-1FDF81D1-7068-4EE4-AF71-0FD39B80FF7EQ41807253-6A61A4AE-F881-470A-8828-D954B5C700E0Q41826178-5AD9F41B-ECB4-449D-9435-03952F57BE3AQ42153590-40D97B6A-A28E-4BA7-BEBF-BEEAC2DE98B0Q42549724-4182C0E2-6C5B-4DE0-B90C-BB2BC26C3753Q42818000-482C2B6E-C41F-4F4A-BDCA-51D96129F818Q46881707-9B86B804-D1F8-49E8-AAE1-90B9276143A2Q47222639-7E931798-0849-464C-8323-FE0B037A6DBDQ47680427-2067A4B0-F953-4BEC-9198-76235555F68CQ48372527-222E61C5-541B-4A0C-87BA-2E6DCCF73920Q48602509-EAE11AB5-FD5D-4588-BE72-86DD233729DDQ50763742-61A54016-5A78-4A89-B036-597B897C3BA5Q59103165-1725C753-21FF-4654-AAF3-FA84913D6BF0
P2860
Effect of drug type on the degradation rate of PLGA matrices
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of drug type on the degradation rate of PLGA matrices
@ast
Effect of drug type on the degradation rate of PLGA matrices
@en
Effect of drug type on the degradation rate of PLGA matrices
@nl
type
label
Effect of drug type on the degradation rate of PLGA matrices
@ast
Effect of drug type on the degradation rate of PLGA matrices
@en
Effect of drug type on the degradation rate of PLGA matrices
@nl
prefLabel
Effect of drug type on the degradation rate of PLGA matrices
@ast
Effect of drug type on the degradation rate of PLGA matrices
@en
Effect of drug type on the degradation rate of PLGA matrices
@nl
P2093
P3181
P1476
Effect of drug type on the degradation rate of PLGA matrices
@en
P2093
Jonathan B Kahn
Karen I Winey
Kathryn Werner
Kayla Metzger
Steven J Siegel
P304
P3181
P356
10.1016/J.EJPB.2006.06.009
P407
P577
2006-11-01T00:00:00Z